1 Study Coverage
1.1 Bifidobacterium Longum Product Introduction
1.2 Market by Type
1.2.1 Global Bifidobacterium Longum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.2g/Piece
1.2.3 0.25g/Piece
1.3 Market by Application
1.3.1 Global Bifidobacterium Longum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medicine
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bifidobacterium Longum Sales Estimates and Forecasts 2017-2028
2.2 Global Bifidobacterium Longum Revenue Estimates and Forecasts 2017-2028
2.3 Global Bifidobacterium Longum Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bifidobacterium Longum Sales by Region
2.4.1 Global Bifidobacterium Longum Sales by Region (2017-2022)
2.4.2 Global Sales Bifidobacterium Longum by Region (2023-2028)
2.5 Global Bifidobacterium Longum Revenue by Region
2.5.1 Global Bifidobacterium Longum Revenue by Region (2017-2022)
2.5.2 Global Bifidobacterium Longum Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bifidobacterium Longum Sales by Manufacturers
3.1.1 Global Top Bifidobacterium Longum Manufacturers by Sales (2017-2022)
3.1.2 Global Bifidobacterium Longum Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bifidobacterium Longum in 2021
3.2 Global Bifidobacterium Longum Revenue by Manufacturers
3.2.1 Global Bifidobacterium Longum Revenue by Manufacturers (2017-2022)
3.2.2 Global Bifidobacterium Longum Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bifidobacterium Longum Revenue in 2021
3.3 Global Bifidobacterium Longum Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bifidobacterium Longum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bifidobacterium Longum Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bifidobacterium Longum Sales by Type
4.1.1 Global Bifidobacterium Longum Historical Sales by Type (2017-2022)
4.1.2 Global Bifidobacterium Longum Forecasted Sales by Type (2023-2028)
4.1.3 Global Bifidobacterium Longum Sales Market Share by Type (2017-2028)
4.2 Global Bifidobacterium Longum Revenue by Type
4.2.1 Global Bifidobacterium Longum Historical Revenue by Type (2017-2022)
4.2.2 Global Bifidobacterium Longum Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
4.3 Global Bifidobacterium Longum Price by Type
4.3.1 Global Bifidobacterium Longum Price by Type (2017-2022)
4.3.2 Global Bifidobacterium Longum Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bifidobacterium Longum Sales by Application
5.1.1 Global Bifidobacterium Longum Historical Sales by Application (2017-2022)
5.1.2 Global Bifidobacterium Longum Forecasted Sales by Application (2023-2028)
5.1.3 Global Bifidobacterium Longum Sales Market Share by Application (2017-2028)
5.2 Global Bifidobacterium Longum Revenue by Application
5.2.1 Global Bifidobacterium Longum Historical Revenue by Application (2017-2022)
5.2.2 Global Bifidobacterium Longum Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
5.3 Global Bifidobacterium Longum Price by Application
5.3.1 Global Bifidobacterium Longum Price by Application (2017-2022)
5.3.2 Global Bifidobacterium Longum Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bifidobacterium Longum Market Size by Type
6.1.1 North America Bifidobacterium Longum Sales by Type (2017-2028)
6.1.2 North America Bifidobacterium Longum Revenue by Type (2017-2028)
6.2 North America Bifidobacterium Longum Market Size by Application
6.2.1 North America Bifidobacterium Longum Sales by Application (2017-2028)
6.2.2 North America Bifidobacterium Longum Revenue by Application (2017-2028)
6.3 North America Bifidobacterium Longum Market Size by Country
6.3.1 North America Bifidobacterium Longum Sales by Country (2017-2028)
6.3.2 North America Bifidobacterium Longum Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Bifidobacterium Longum Market Size by Type
7.1.1 Europe Bifidobacterium Longum Sales by Type (2017-2028)
7.1.2 Europe Bifidobacterium Longum Revenue by Type (2017-2028)
7.2 Europe Bifidobacterium Longum Market Size by Application
7.2.1 Europe Bifidobacterium Longum Sales by Application (2017-2028)
7.2.2 Europe Bifidobacterium Longum Revenue by Application (2017-2028)
7.3 Europe Bifidobacterium Longum Market Size by Country
7.3.1 Europe Bifidobacterium Longum Sales by Country (2017-2028)
7.3.2 Europe Bifidobacterium Longum Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bifidobacterium Longum Market Size by Type
8.1.1 Asia Pacific Bifidobacterium Longum Sales by Type (2017-2028)
8.1.2 Asia Pacific Bifidobacterium Longum Revenue by Type (2017-2028)
8.2 Asia Pacific Bifidobacterium Longum Market Size by Application
8.2.1 Asia Pacific Bifidobacterium Longum Sales by Application (2017-2028)
8.2.2 Asia Pacific Bifidobacterium Longum Revenue by Application (2017-2028)
8.3 Asia Pacific Bifidobacterium Longum Market Size by Region
8.3.1 Asia Pacific Bifidobacterium Longum Sales by Region (2017-2028)
8.3.2 Asia Pacific Bifidobacterium Longum Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Bifidobacterium Longum Market Size by Type
9.1.1 Latin America Bifidobacterium Longum Sales by Type (2017-2028)
9.1.2 Latin America Bifidobacterium Longum Revenue by Type (2017-2028)
9.2 Latin America Bifidobacterium Longum Market Size by Application
9.2.1 Latin America Bifidobacterium Longum Sales by Application (2017-2028)
9.2.2 Latin America Bifidobacterium Longum Revenue by Application (2017-2028)
9.3 Latin America Bifidobacterium Longum Market Size by Country
9.3.1 Latin America Bifidobacterium Longum Sales by Country (2017-2028)
9.3.2 Latin America Bifidobacterium Longum Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bifidobacterium Longum Market Size by Type
10.1.1 Middle East and Africa Bifidobacterium Longum Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bifidobacterium Longum Revenue by Type (2017-2028)
10.2 Middle East and Africa Bifidobacterium Longum Market Size by Application
10.2.1 Middle East and Africa Bifidobacterium Longum Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bifidobacterium Longum Revenue by Application (2017-2028)
10.3 Middle East and Africa Bifidobacterium Longum Market Size by Country
10.3.1 Middle East and Africa Bifidobacterium Longum Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bifidobacterium Longum Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ATCC Inc
11.1.1 ATCC Inc Corporation Information
11.1.2 ATCC Inc Overview
11.1.3 ATCC Inc Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ATCC Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ATCC Inc Recent Developments
11.2 BioGaia AB
11.2.1 BioGaia AB Corporation Information
11.2.2 BioGaia AB Overview
11.2.3 BioGaia AB Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BioGaia AB Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioGaia AB Recent Developments
11.3 Mystic Pharmaceuticals Inc
11.3.1 Mystic Pharmaceuticals Inc Corporation Information
11.3.2 Mystic Pharmaceuticals Inc Overview
11.3.3 Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mystic Pharmaceuticals Inc Recent Developments
11.4 Hanson Ltd
11.4.1 Hanson Ltd Corporation Information
11.4.2 Hanson Ltd Overview
11.4.3 Hanson Ltd Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hanson Ltd Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hanson Ltd Recent Developments
11.5 Biofodan A/S
11.5.1 Biofodan A/S Corporation Information
11.5.2 Biofodan A/S Overview
11.5.3 Biofodan A/S Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biofodan A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biofodan A/S Recent Developments
11.6 BioCare Copenhagen ApS
11.6.1 BioCare Copenhagen ApS Corporation Information
11.6.2 BioCare Copenhagen ApS Overview
11.6.3 BioCare Copenhagen ApS Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 BioCare Copenhagen ApS Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BioCare Copenhagen ApS Recent Developments
11.7 Danisco A/S
11.7.1 Danisco A/S Corporation Information
11.7.2 Danisco A/S Overview
11.7.3 Danisco A/S Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Danisco A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Danisco A/S Recent Developments
11.8 Danone SA
11.8.1 Danone SA Corporation Information
11.8.2 Danone SA Overview
11.8.3 Danone SA Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Danone SA Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Danone SA Recent Developments
11.9 Deerland Enzymes Inc.
11.9.1 Deerland Enzymes Inc. Corporation Information
11.9.2 Deerland Enzymes Inc. Overview
11.9.3 Deerland Enzymes Inc. Bifidobacterium Longum Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Deerland Enzymes Inc. Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Deerland Enzymes Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bifidobacterium Longum Industry Chain Analysis
12.2 Bifidobacterium Longum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bifidobacterium Longum Production Mode & Process
12.4 Bifidobacterium Longum Sales and Marketing
12.4.1 Bifidobacterium Longum Sales Channels
12.4.2 Bifidobacterium Longum Distributors
12.5 Bifidobacterium Longum Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bifidobacterium Longum Industry Trends
13.2 Bifidobacterium Longum Market Drivers
13.3 Bifidobacterium Longum Market Challenges
13.4 Bifidobacterium Longum Market Restraints
14 Key Findings in The Global Bifidobacterium Longum Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bifidobacterium Longum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.2g/Piece
Table 3. Major Manufacturers of 0.25g/Piece
Table 4. Global Bifidobacterium Longum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Bifidobacterium Longum Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Bifidobacterium Longum Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Bifidobacterium Longum Sales Market Share by Region (2017-2022)
Table 8. Global Bifidobacterium Longum Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Bifidobacterium Longum Sales Market Share by Region (2023-2028)
Table 10. Global Bifidobacterium Longum Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Bifidobacterium Longum Revenue Market Share by Region (2017-2022)
Table 12. Global Bifidobacterium Longum Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Bifidobacterium Longum Revenue Market Share by Region (2023-2028)
Table 14. Global Bifidobacterium Longum Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Bifidobacterium Longum Sales Share by Manufacturers (2017-2022)
Table 16. Global Bifidobacterium Longum Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Bifidobacterium Longum Revenue Share by Manufacturers (2017-2022)
Table 18. Bifidobacterium Longum Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 19. Global Bifidobacterium Longum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Bifidobacterium Longum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacterium Longum as of 2021)
Table 21. Bifidobacterium Longum Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bifidobacterium Longum Product Offered
Table 23. Date of Manufacturers Enter into Bifidobacterium Longum Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Bifidobacterium Longum Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Bifidobacterium Longum Sales Share by Type (2017-2022)
Table 28. Global Bifidobacterium Longum Sales Share by Type (2023-2028)
Table 29. Global Bifidobacterium Longum Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Bifidobacterium Longum Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Bifidobacterium Longum Revenue Share by Type (2017-2022)
Table 32. Global Bifidobacterium Longum Revenue Share by Type (2023-2028)
Table 33. Bifidobacterium Longum Price by Type (2017-2022) & (USD/Pcs)
Table 34. Global Bifidobacterium Longum Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 35. Global Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Bifidobacterium Longum Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Bifidobacterium Longum Sales Share by Application (2017-2022)
Table 38. Global Bifidobacterium Longum Sales Share by Application (2023-2028)
Table 39. Global Bifidobacterium Longum Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Bifidobacterium Longum Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Bifidobacterium Longum Revenue Share by Application (2017-2022)
Table 42. Global Bifidobacterium Longum Revenue Share by Application (2023-2028)
Table 43. Bifidobacterium Longum Price by Application (2017-2022) & (USD/Pcs)
Table 44. Global Bifidobacterium Longum Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 45. North America Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Bifidobacterium Longum Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Bifidobacterium Longum Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Bifidobacterium Longum Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Bifidobacterium Longum Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Bifidobacterium Longum Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Bifidobacterium Longum Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Bifidobacterium Longum Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Bifidobacterium Longum Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Bifidobacterium Longum Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Bifidobacterium Longum Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Bifidobacterium Longum Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Bifidobacterium Longum Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Bifidobacterium Longum Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Bifidobacterium Longum Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Bifidobacterium Longum Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Bifidobacterium Longum Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Bifidobacterium Longum Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Bifidobacterium Longum Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Bifidobacterium Longum Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Bifidobacterium Longum Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Bifidobacterium Longum Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Bifidobacterium Longum Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Bifidobacterium Longum Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Bifidobacterium Longum Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Bifidobacterium Longum Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Bifidobacterium Longum Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Bifidobacterium Longum Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Bifidobacterium Longum Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Bifidobacterium Longum Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Bifidobacterium Longum Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Bifidobacterium Longum Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Bifidobacterium Longum Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Bifidobacterium Longum Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Bifidobacterium Longum Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Bifidobacterium Longum Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Bifidobacterium Longum Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Bifidobacterium Longum Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Bifidobacterium Longum Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Bifidobacterium Longum Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Bifidobacterium Longum Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Bifidobacterium Longum Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Bifidobacterium Longum Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Bifidobacterium Longum Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Bifidobacterium Longum Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Bifidobacterium Longum Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Bifidobacterium Longum Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Bifidobacterium Longum Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Bifidobacterium Longum Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Bifidobacterium Longum Revenue by Country (2023-2028) & (US$ Million)
Table 105. ATCC Inc Corporation Information
Table 106. ATCC Inc Description and Major Businesses
Table 107. ATCC Inc Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 108. ATCC Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. ATCC Inc Recent Developments
Table 110. BioGaia AB Corporation Information
Table 111. BioGaia AB Description and Major Businesses
Table 112. BioGaia AB Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. BioGaia AB Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. BioGaia AB Recent Developments
Table 115. Mystic Pharmaceuticals Inc Corporation Information
Table 116. Mystic Pharmaceuticals Inc Description and Major Businesses
Table 117. Mystic Pharmaceuticals Inc Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Mystic Pharmaceuticals Inc Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Mystic Pharmaceuticals Inc Recent Developments
Table 120. Hanson Ltd Corporation Information
Table 121. Hanson Ltd Description and Major Businesses
Table 122. Hanson Ltd Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Hanson Ltd Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Hanson Ltd Recent Developments
Table 125. Biofodan A/S Corporation Information
Table 126. Biofodan A/S Description and Major Businesses
Table 127. Biofodan A/S Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Biofodan A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biofodan A/S Recent Developments
Table 130. BioCare Copenhagen ApS Corporation Information
Table 131. BioCare Copenhagen ApS Description and Major Businesses
Table 132. BioCare Copenhagen ApS Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. BioCare Copenhagen ApS Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. BioCare Copenhagen ApS Recent Developments
Table 135. Danisco A/S Corporation Information
Table 136. Danisco A/S Description and Major Businesses
Table 137. Danisco A/S Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. Danisco A/S Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Danisco A/S Recent Developments
Table 140. Danone SA Corporation Information
Table 141. Danone SA Description and Major Businesses
Table 142. Danone SA Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. Danone SA Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Danone SA Recent Developments
Table 145. Deerland Enzymes Inc. Corporation Information
Table 146. Deerland Enzymes Inc. Description and Major Businesses
Table 147. Deerland Enzymes Inc. Bifidobacterium Longum Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Deerland Enzymes Inc. Bifidobacterium Longum Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Deerland Enzymes Inc. Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Bifidobacterium Longum Distributors List
Table 153. Bifidobacterium Longum Customers List
Table 154. Bifidobacterium Longum Market Trends
Table 155. Bifidobacterium Longum Market Drivers
Table 156. Bifidobacterium Longum Market Challenges
Table 157. Bifidobacterium Longum Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Bifidobacterium Longum Product Picture
Figure 3. Global Bifidobacterium Longum Market Share by Type in 2021 & 2028
Figure 3. 0.2g/Piece Product Picture
Figure 4. 0.25g/Piece Product Picture
Figure 5. Global Bifidobacterium Longum Market Share by Application in 2021 & 2028
Figure 6. Medicine
Figure 7. Others
Figure 8. Bifidobacterium Longum Report Years Considered
Figure 9. Global Bifidobacterium Longum Sales 2017-2028 (K Pcs)
Figure 10. Global Bifidobacterium Longum Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Bifidobacterium Longum Revenue 2017-2028 (US$ Million)
Figure 12. Global Bifidobacterium Longum Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Bifidobacterium Longum Sales Market Share by Region (2017-2022)
Figure 14. Global Bifidobacterium Longum Sales Market Share by Region (2023-2028)
Figure 15. North America Bifidobacterium Longum Sales YoY (2017-2028) & (K Pcs)
Figure 16. North America Bifidobacterium Longum Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Bifidobacterium Longum Sales YoY (2017-2028) & (K Pcs)
Figure 18. Europe Bifidobacterium Longum Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Bifidobacterium Longum Sales YoY (2017-2028) & (K Pcs)
Figure 20. Asia-Pacific Bifidobacterium Longum Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Bifidobacterium Longum Sales YoY (2017-2028) & (K Pcs)
Figure 22. Latin America Bifidobacterium Longum Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Bifidobacterium Longum Sales YoY (2017-2028) & (K Pcs)
Figure 24. Middle East & Africa Bifidobacterium Longum Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Bifidobacterium Longum Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Bifidobacterium Longum in the World: Market Share by Bifidobacterium Longum Revenue in 2021
Figure 27. Global Bifidobacterium Longum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Bifidobacterium Longum Sales Market Share by Type (2017-2028)
Figure 29. Global Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
Figure 30. Global Bifidobacterium Longum Sales Market Share by Application (2017-2028)
Figure 31. Global Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
Figure 32. North America Bifidobacterium Longum Sales Market Share by Type (2017-2028)
Figure 33. North America Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
Figure 34. North America Bifidobacterium Longum Sales Market Share by Application (2017-2028)
Figure 35. North America Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
Figure 36. North America Bifidobacterium Longum Sales Share by Country (2017-2028)
Figure 37. North America Bifidobacterium Longum Revenue Share by Country (2017-2028)
Figure 38. U.S. Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Bifidobacterium Longum Sales Market Share by Type (2017-2028)
Figure 41. Europe Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
Figure 42. Europe Bifidobacterium Longum Sales Market Share by Application (2017-2028)
Figure 43. Europe Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
Figure 44. Europe Bifidobacterium Longum Sales Share by Country (2017-2028)
Figure 45. Europe Bifidobacterium Longum Revenue Share by Country (2017-2028)
Figure 46. Germany Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 47. France Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Bifidobacterium Longum Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Bifidobacterium Longum Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Bifidobacterium Longum Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Bifidobacterium Longum Revenue Share by Region (2017-2028)
Figure 57. China Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 60. India Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Bifidobacterium Longum Sales Market Share by Type (2017-2028)
Figure 68. Latin America Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Bifidobacterium Longum Sales Market Share by Application (2017-2028)
Figure 70. Latin America Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Bifidobacterium Longum Sales Share by Country (2017-2028)
Figure 72. Latin America Bifidobacterium Longum Revenue Share by Country (2017-2028)
Figure 73. Mexico Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Bifidobacterium Longum Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Bifidobacterium Longum Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Bifidobacterium Longum Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Bifidobacterium Longum Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Bifidobacterium Longum Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Bifidobacterium Longum Revenue Share by Country (2017-2028)
Figure 82. Turkey Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Bifidobacterium Longum Revenue (2017-2028) & (US$ Million)
Figure 85. Bifidobacterium Longum Value Chain
Figure 86. Bifidobacterium Longum Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ATCC Inc BioGaia AB Mystic Pharmaceuticals Inc Hanson Ltd Biofodan A/S BioCare Copenhagen ApS Danisco A/S Danone SA Deerland Enzymes Inc.